Related Experiment Videos
[Milrinone suppresses TNF-alpha and IL-1 beta release in mouse peritoneal macrophages]
Abstract:
Tumor necrosis factor-alpha (TNF-alpha) exerts a wide spectrum of biological activities and contributes to the pathophysiology of septic shock. We studied whether milrinone suppresses TNF-alpha and IL-1 beta releases from mouse peritoneal macrophages. Mouse peritoneal macrophages were stimulated for 18 hr with lipopolysaccharide and different doses of milrinone. TNF-alpha release was suppressed in a dose-dependent fashion with milrinone, reaching half-maximal inhibition at 30 microM. Release of IL-1 beta was not suppressed with 25 microM of milrinone, but it was suppressed with 250 microM of milrinone. We conclude that TNF-alpha release is suppressed by therapeutically administered milrinone.
Insights
Milrinone effectively suppresses tumor necrosis factor-alpha (TNF-alpha) release from macrophages in a dose-dependent manner. This finding suggests milrinone
Area of Science:
- Immunology
- Pharmacology
Background:
- Tumor necrosis factor-alpha (TNF-alpha) plays a key role in septic shock.
- Understanding modulators of inflammatory cytokine release is crucial for treating sepsis.
Purpose of the Study:
- To investigate the effect of milrinone on the release of TNF-alpha and IL-1 beta from mouse peritoneal macrophages.
- To determine if milrinone exhibits dose-dependent suppression of these cytokines.
Main Methods:
- Mouse peritoneal macrophages were stimulated with lipopolysaccharide.
- Cells were treated with varying doses of milrinone for 18 hours.
- TNF-alpha and IL-1 beta levels in the supernatant were measured.
Main Results:
- Milrinone significantly suppressed TNF-alpha release in a dose-dependent manner, with half-maximal inhibition at 30 microM.
- IL-1 beta release was not affected by 25 microM milrinone but was suppressed at 250 microM.
- These results indicate differential effects of milrinone on cytokine production.
Conclusions:
- Therapeutically administered milrinone can suppress TNF-alpha release.
- Milrinone may have a role in managing conditions associated with elevated TNF-alpha, such as septic shock.